Kenny Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 7.50 M
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.26 Cr
- Satisfied Charges ₹ 5.50 M
- Revenue Growth 19.96%
- Profit Growth 124.55%
- Ebitda 177.79%
- Net Worth 25.00%
- Total Assets 36.72%
About Kenny Pharma
Kenny Pharma Private Limited (KPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 11 June 2003 and has a history of 21 years and seven months. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹3.26 Cr. The company has closed loans amounting to ₹5.50 M, as per Ministry of Corporate Affairs (MCA) records.
Valamjibhai Desai and Nitaben Desai serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231GJ2003PTC042495
-
Company No.
042495
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Jun 2003
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Kenny Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Valamjibhai Desai
|
Director | 01-Jul-2003 | Current |
|
Nitaben Desai
|
Director | 10-Mar-2014 | Current |
Financial Performance of Kenny Pharma.
Kenny Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19.96% increase. The company also saw a substantial improvement in profitability, with a 124.55% increase in profit. The company's net worth Soared by an impressive increase of 25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kenny Pharma?
In 2021, Kenny Pharma had a promoter holding of 36.01% and a public holding of 63.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.26 Cr
₹0.55 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 3.26 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2008 | State Bank Of India | ₹1.88 Cr | Open |
| 16 Feb 2008 | State Bank Of India | ₹1.38 Cr | Open |
| 29 Jul 2005 | Navsarjan Industrial Co-Operative Bank Limited | ₹1.00 M | Satisfied |
| 29 Jul 2005 | Navsarjan Industrial Co-Op. Bank Ltd. | ₹3.00 M | Satisfied |
| 31 Jan 2004 | Oriental Bank Of Commerce | ₹0.75 M | Satisfied |
How Many Employees Work at Kenny Pharma?
Kenny Pharma has a workforce of 22 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kenny Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kenny Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
